Molecular epidemiology in HCV-related hepatocellular carcinoma: First steps

被引:4
|
作者
Villanueva, Augusto [1 ,2 ]
Forns, Xavier [2 ,3 ]
Llovet, Josep M. [1 ,2 ,4 ]
机构
[1] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona Clin Liver Canc Grp, HCC Translat Res Lab,Liver Unit, E-08036 Barcelona, Spain
[2] Inst Salud Carlos III, CIBEREHD, Madrid, Spain
[3] Hosp Clin Barcelona, Liver Unit, Viral Hepatitis Lab, E-08036 Barcelona, Spain
[4] Mt Sinai Sch Med, Liver Canc Program, New York, NY USA
关键词
Epidemiology; HCC; HCV; GENOME-WIDE ASSOCIATION; LOCUS;
D O I
10.1016/j.jhep.2012.01.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic viral hepatitis is the most important risk factor for progression to hepatocellular carcinoma (HCC). To identify genetic risk factors for progression to HCC in individuals with chronic hepatitis C virus (HCV), we analyzed 467,538 SNPs in 212 Japanese individuals with chronic HCV with HCC and 765 individuals with chronic HCV without HCC. We identified one intronic SNP in the DEPDC5 locus on chromosome 22 associated with HCC risk and confirmed the association using an independent case-control population (710 cases and 1625 controls). The association was highly significant when we analyzed the stages separately as well as together (rs1012068, P(combined) = 1.27 x 10(-13), odds ratio = 1.75). The significance level of the association further increased after adjustment for gender, age, and platelet count (P = 1.35 x 10(-14), odds ratio = 1.96). Our findings suggest that common variants within the DEPDC5 locus affect susceptibility to HCC in Japanese individuals with chronic HCV infection. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:213 / 214
页数:2
相关论文
共 50 条
  • [1] Increasing survival in HCV-related hepatocellular carcinoma
    Ray K.
    [J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16 (10) : 582 - 582
  • [2] Familial clustering of HCV-related hepatocellular carcinoma (HCC)
    Pasta, L
    Bevacqua, EA
    Marrone, C
    d'Amico, M
    D'Amico, G
    Pagliaro, L
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A761 - A761
  • [3] The risk of hepatocellular carcinoma in HCV-related chronic hepatitis
    Omata, M.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S11 - S11
  • [4] Genetic Variability in Patients with HCV-Related Hepatocellular Carcinoma
    Pisaturo, Mariantonietta
    Di Fraia, Alessandra
    Occhiello, Laura
    Minichini, Carmine
    Starace, Mario
    Iodice, Valentina
    Farella, Nunzia
    Stanzione, Maria
    Coppola, Nicola
    [J]. INFECTION AND DRUG RESISTANCE, 2021, 14 : 5199 - 5208
  • [5] Does chemotherapy prevent HCV-related hepatocellular carcinoma? Pros
    Masuzaki, Ryota
    Yoshida, Haruhiko
    Omata, Masao
    [J]. DIGESTIVE AND LIVER DISEASE, 2010, 42 : S281 - S286
  • [6] Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons
    Craxi, Antonio
    Camma, Calogero
    [J]. DIGESTIVE AND LIVER DISEASE, 2010, 42 : S287 - S292
  • [7] Familial clustering of HCV-related liver cirrhosis and hepatocellular carcinoma
    Pasta, L
    Marrone, C
    D'amico, M
    Bevacqua, EA
    D'Amico, G
    Pagliaro, L
    [J]. DIGESTIVE AND LIVER DISEASE, 2005, 37 (09) : 716 - 717
  • [8] HCV-related hepatocellular carcinoma: From chronic inflammation to cancer
    Castello, Giuseppe
    Scala, Stefania
    Palmieri, Giuseppe
    Curley, Steven A.
    Izzo, Francesco
    [J]. CLINICAL IMMUNOLOGY, 2010, 134 (03) : 237 - 250
  • [9] EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma
    Wang, Jia
    Zhong, Yanlin
    Meng, Guixia
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2053 - 2064
  • [10] EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma
    Jia Wang
    Yanlin Zhong
    Guixia Meng
    [J]. International Journal of Clinical Oncology, 2021, 26 : 2053 - 2064